Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mo | Bavarian Nordic A/S: Bavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic Reserve | 339 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, April 29, 2024 - Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract valued at EUR 65 million to supply its MVA-BN® smallpox vaccine to the strategic reserve... ► Artikel lesen | |
Mo | Bavarian Nordic A/S: Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate | 421 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, April 29, 2024 - Bavarian Nordic A/S (OMX: BAVA) today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration (FDA) for a Biologics... ► Artikel lesen | |
22.04. | Bavarian Nordic A/S: Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such | 10 | GlobeNewswire (USA) | ||
22.04. | EQS-Adhoc: BAVARIA Industries Group AG: Kündigung Einbeziehung Freiverkehr | 879 | EQS Group (DE) | EQS-Ad-hoc: BAVARIA Industries Group AG / Schlagwort(e): Delisting
BAVARIA Industries Group AG: Kündigung Einbeziehung Freiverkehr
22.04.2024 / 16:21 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
16.04. | Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S | 73 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, April 16, 2024 - Bavarian Nordic A/S (OMX: BAVA) today held the Annual General Meeting with the following results: The Annual Report for 2023 was adopted. The Board of Directors'... ► Artikel lesen | |
03.04. | Bavarian Nordic announces commercial availability of mpox vaccine in US | 380 | Pharmaceutical Business Review | ||
02.04. | Bavarian Nordic expands access to mpox vaccine in US | 72 | Pharmaceutical Technology | ||
02.04. | Bavarian Nordic: Wichtige Mitteilung - so reagiert die Aktie | 340 | finanztreff.de | Bavarian Nordic hat am Dienstagmorgen die Markteinführung von JYNNEOS® in den Vereinigten Staaten angekündigt, einem Meilenstein, der die Präsenz des Unternehmens im Kampf gegen Mpox unterstreicht.... ► Artikel lesen | |
02.04. | Bavarian Nordic A/S: Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S. | 184 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, April 2, 2024 - Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially available in the U.S., marking a significant... ► Artikel lesen | |
26.03. | Bavaria Fiction verpasst seiner Doku-Einheit einen Namen | 1 | DWDL | ||
21.03. | Bavarian Nordic A/S - Notice Convening Annual General Meeting | 4 | GlobeNewswire (USA) | ||
15.03. | SLYRS Bavarian Whisky Distillery präsentiert erste OnPack Aktion im Handel | 1 | about-drinks.com | ||
13.03. | Bavarian Nordic A/S: Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland | 283 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, March 13, 2024 - Bavarian Nordic A/S (OMX: BAVA) announced today that the Swiss Agency for Therapeutic Products, Swissmedic, has approved JYNNEOS® (MVA-BN) for active immunization... ► Artikel lesen | |
12.03. | Bavarian Nordic A/S: Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such | 232 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, March 12, 2024 - Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company's shares/related securities by persons holding managerial... ► Artikel lesen | |
07.03. | Earnings call: Bavarian Nordic posts record revenue, eyes growth in vaccines | 16 | Investing.com | ||
06.03. | Bavarian Nordic A/S: Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such | 9 | GlobeNewswire (USA) | ||
06.03. | Bavarian Nordic A/S: Bavarian Nordic Publishes Annual Report 2023 | 734 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, March 6, 2024 - Bavarian Nordic A/S.
Paul Chaplin, President & Chief Executive Officer of Bavarian Nordic said: "Delivering our best-ever financial results in 2023, we are now... ► Artikel lesen | |
05.03. | OsaBus Expands Fleet with New Setra and Volvo Buses, Enhancing Passenger Transportation in Bavaria and Beyond | 205 | Business Wire | OsaBus, a preeminent charter bus rental company in Europe, proudly announces a significant expansion of its fleet with the addition of new Setra and Volvo buses, representing an investment of €2... ► Artikel lesen | |
23.02. | Bavarian Nordic's chikungunya vaccine secures EMA fast-track | 23 | Pharmaceutical Technology | ||
23.02. | Bavarian Nordic gets swift EU review of chikungunya shot | 3 | pharmaphorum |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 416 |
BAYER | 269 |
BYD | 239 |
NVIDIA | 225 |
NEL | 219 |
PLUG POWER | 196 |
TESLA | 190 |
SUPER MICRO COMPUTER | 185 |
TUI | 185 |
DEUTSCHE BANK | 179 |
APPLE | 177 |
RHEINMETALL | 157 |
AMAZON | 144 |
RWE | 144 |
DEUTSCHE LUFTHANSA | 141 |
MERCEDES-BENZ | 135 |
BERKSHIRE HATHAWAY | 125 |
COMMERZBANK | 116 |
PAYPAL | 114 |
BIONTECH | 113 |
ALLIANZ | 110 |
BASF | 110 |
AIXTRON SE | 108 |
RENK GROUP | 108 |
VOLKSWAGEN | 107 |